• Stay Abreast of 340B Happenings

    It’s that time of year again! The 340B Coalition Winter Conference is upon us. Taking place January 30 – February 1 in San Diego, CA, this prestigious conference offers health care providers, contract pharmacies, pharmaceutical manufacturers, 340B-oriented businesses and government agencies opportunities to network with other 340B leaders and stay informed of the latest industry… Read more »

  • 340B Insider – December 2018

    Welcome to the December edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view. Visit our website to read more.   340B INDUSTRY NEWS Read below for recent news from 340B Health. THE U.S. HOUSE PASSES BILL TO KEEP DRUG COMPANIES FROM OVERCHARGING MEDICAID The bipartisan bill, from… Read more »

  • Ensure Effective 340B Management in 2019

    As we near the New Year, health systems nationwide are seeking the most effective processes and services for enterprise 340B program management. Ensure compliance and efficiency in 2019 with RxStrategies, the clear choice for innovative software, high-touch service, unwavering program compliance and maximum 340B savings. Our robust retail and specialty pharmacy networks deliver high capture… Read more »

  • 340B Insider – November 2018

                  Welcome to the November 2018 edition of RxStrategies’ 340B Insider, a concise communication to provide a quick highlight of updates from RxStrategies’ view.   340B INDUSTRY NEWS Read below for recent news from 340B Health. MEDICARE 340B CUTS WILL CONTINUE AND EXPAND IN 2019 Medicare cuts of nearly 30 percent… Read more »

  • Spreading Gratitude

    Our team is honored to serve and support your organization. Thank you for the opportunity to partner alongside you as your strive for program compliance while serving your community. May you and your family have a wonderful Thanksgiving holiday. With Gratitude, The RxStrategies Team

  • Maximize 340B Program Results

    RxStrategies prides itself on offering intuitive contract pharmacy management through advanced reporting and analytics. Our conservative approach to 340B maximizes program results by ensuring more of the 340B savings remain with Covered Entity (CE) through a simple, all-inclusive fee. Another way our contract pharmacy solution is able to maximize results is through our audit-proven eligibility… Read more »

  • Ready for Some Midyear Magic

    The RxStrategies team is ready for some midyear magic at the ASHP Midyear Conference being held December 2-6. At this prestigious conference – the largest global gathering of pharmacy professionals – RxStrategies team members Skip Devanny, Rhodie Smith and Jonathan Ghenn will network with more than 25,000 pharmacy professionals and discuss current trends, news and… Read more »

  • Clinical Insights: November 7, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Lorbrena® (lorlatinib) – New Drug Approval – November 2, 2018 – The Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with… Read more »

  • Clinical Insights: October 10, 2018

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval TegsediTM (inotersen) – October 5, 2018 – Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc., announced that the U.S. Food and Drug… Read more »